Breaking Down SCOR SE Financial Health: Key Insights for Investors

A sharp, numbers-driven snapshot of SCOR SE's financial pulse demands attention: Q1 2025 delivered a net income of €200 million powered by resilient segments and a Life & Health insurance service result of €118 million (up 65% year-on-year), while underwriting discipline shows in P&C's combined ratio at 85.0% (improving to 82.5% in Q2) and an investment yield contributing a steady 3.5% to returns; capital strength reads strong too with a Group solvency ratio at 212% in Q1 2025 and financial leverage trimmed to 23.6%, even as market valuation points to possible upside with a market cap of $4.58 billion and shares trading near a 5.4x 2025 EPS multiple - all set against downside flags like the ~€140 million hit from the January 2025 California wildfires and analyst rating shifts that make this a must-read for investors weighing risk, value and growth ahead

SCOR SE (SCR.PA) - Revenue Analysis

• Net income Q1 2025: €200 million.
• P&C combined ratio (Q1 2025): 85.0% - indicating underwriting profitability.
• L&H insurance service result Q1 2025: €118 million, a 65% year-on-year increase.
• Investment regular income yield: 3.5%, supporting recurring revenue.
• P&C insurance revenue (Q4 2024 reference): ~€2.0 billion, stable quarter-to-quarter.

• P&C: Stable top-line (~€2.0bn) with improved loss control - combined ratio at 85.0% implies underwriting contribution to profit.
• L&H: Rapid margin expansion - insurance service result up 65% to €118m, boosting overall profitability.
• Investments: Regular income yield of 3.5% provides predictable yield support amid volatile markets.

SCOR SE (SCR.PA) Profitability Metrics

• Annualized Return on Equity (ROE): 18.7% in Q1 2025.
• P&C combined ratio: 85.0% in Q1 2025; improved to 82.5% in Q2 2025.
• L&H insurance service result: €118 million in Q1 2025 and €118 million in Q2 2025.
• Investment portfolio regular income yield: 3.5% in Q1 2025.

• Underwriting efficiency: P&C combined ratio falling from 85.0% to 82.5% indicates improving loss experience and expense control, lifting underwriting margins.
• L&H stability: Repeated €118M quarterly insurance service results point to consistent operational earnings in life & health.
• Capital profitability: ROE of 18.7% signals effective capital deployment relative to peers and supports shareholder returns potential.
• Investment contribution: A 3.5% regular income yield provides a predictable earnings stream that complements underwriting results.

SCOR SE (SCR.PA) - Debt vs. Equity Structure

• Financial leverage (debt/equity) improved to 23.6% in Q1 2025, down from 24.5% at year-end 2024 - a sign of lower relative indebtedness.
• Group solvency ratio: remained within the insurer's stated optimal range (185%-220%) across 2025, signaling robust capital adequacy.

• Capital buffer: Solvency ratio readings of ~210%-212% indicate strong equity relative to technical and market risks, providing room for underwriting flexibility and potential balance-sheet management initiatives.
• Directionality: The reduction in leverage (24.5% → 23.6%) coupled with a 2‑point uptick in solvency in Q1 2025 suggests capital strengthening via retained earnings, asset revaluation, or deleveraging measures.
• Investor implication: A solvency ratio consistently near the upper part of the 185%-220% range reduces tail risk for creditors and policyholders while preserving capacity for growth or selective capital returns.

SCOR SE (SCR.PA) Liquidity and Solvency

SCOR SE demonstrates robust capital adequacy and liquidity positioning through 2025, with solvency metrics consistently inside the group's stated optimal range (185%-220%).

• Group Solvency Ratio - Q1 2025: 212% (up 2 percentage points vs year-end 2024).
• Group Solvency Ratio - Q2 2025: 210% (upper part of the optimal 185%-220% range).
• Group Solvency Ratio - Q3 2025: 210% (stable and within the optimal range).
• Regulatory/target context: optimal solvency range defined as 185%-220% for capital planning and dividend capacity.

• Implications for investors: sustained solvency above 185% supports capital return potential and resilience to underwriting or market shocks.
• Trend note: Q1 uptick to 212% indicates a modest capital buffer improvement; subsequent quarters show consolidation around 210%.
• Monitoring points: continued stability of the solvency ratio, investment portfolio volatility, and reinsurer credit exposure.

For broader context on SCOR's strategy and operations, see: SCOR SE: History, Ownership, Mission, How It Works & Makes Money

SCOR SE (SCR.PA) - Valuation Analysis

• Valuation snapshot: 5.4× 2025 EPS; P/B = 1.0; Market cap = $4.58B; proximity to 52-week high (€27.52).
• Analyst sentiment is mixed - upgrades and downgrades coexist, producing a range of price targets and signalling divergent expectations about earnings momentum and reserve dynamics.
• Price targets: Berenberg €24.00 (upgrade to Buy), Citi €21.40 (revised to Neutral), HSBC €33 (downgraded to Hold with a €33 target).

• Implications for investors:
  • A 5.4× 2025 EPS multiple implies limited price appreciation baked into current earnings forecasts; any upside to EPS could materially lift valuation.
  • P/B ~1.0 reduces downside from accounting-write-down scenarios but means limited margin for error on reserve deterioration or large catastrophe losses.
  • Divergent analyst targets (€21.40-€33.00) indicate dispersion in expectations - monitor upcoming earnings, reserve releases, and investment income updates.

SCOR SE (SCR.PA) - Risk Factors

• Catastrophe exposure: January 2025 California wildfires - estimated direct impact €140 million; industry models suggest a 10-25% step-up in short-term P&C loss volatility following similar concentrated events.
• Tariff-driven inflation risk: SCOR anticipates potential inflationary pressures from changing U.S. tariffs. Scenario analysis by management indicates a 0.5-1.5 percentage point negative impact on underwriting margins under sustained tariff-driven cost inflation.
• Reinsurance loss surprises: Analysts at Citi and HSBC have flagged the risk of unexpected loss emergence in property & casualty reinsurance lines, which could pressure both combined ratios and share performance if loss development deteriorates beyond modeled assumptions.
• Longevity and mortality trends: Adverse longevity trends - notably in the U.S. mortality segment - increase uncertainty in Life & Health reserving and profitability. Stress scenarios presented internally show a potential mid-single-digit percentage reduction in Life & Health segment operating profit under sustained negative mortality developments.
• Solvency model changes: Proposed or implemented changes to solvency frameworks (capital calibration or model assumptions) could raise capital requirements and affect capital allocation; management sensitivity analyses show solvency capital requirement (SCR) coverage could move by several percentage points under certain model amendments.
• Geopolitical and climate risk: Rising geopolitical tensions and climate-change-related frequency/severity of natural catastrophes increase the probability of large loss years and reserve strengthening requirements.

• Short-term watchlist: reserve strengthening, Q1-Q2 2025 loss development, reinsurance program exhaustion after major nat-cat months.
• Medium-term watchlist: solvency model consultations, tariff policy shifts and their inflation pass-through into claims and repair/rebuild costs.
• Data triggers: quarterly reserve development tables, catastrophe notes, mortality tables for U.S. blocks, and regulatory filings addressing capital model changes.

SCOR SE (SCR.PA) - Growth Opportunities

SCOR SE's recent results and strategic positioning point to multiple growth drivers that investors should weigh. Key quantitative signals from the April 2025 renewals and corporate guidance highlight momentum across premiums, shareholder returns, and strategic targets.

• Estimated Gross Premium Income (EGPI) growth of 1.5% in April 2025 renewals, demonstrating positive top-line momentum in reinsurance placements.
• Proposed annual dividend of €1.80 per share - a shareholder-return signal aligned with market forecasts and supportive of income-focused investors.
• Berenberg upgrade to a Buy rating with an increased price target of €24.00, reflecting increased analyst confidence in near- to mid-term upside.
• Forward 2026 strategic plan targeting an annualized return on equity (ROE) of >12%, providing a clear quantitative ambition for profitability and capital efficiency.
• Continued strong performance in the U.S. market expected to be a material contributor to growth and margin improvement.
• Strategic diversification into higher-margin and less correlated lines of business to reduce volatility and expand profitable capacity.

Primary growth levers can be summarized as focused premium growth, disciplined capital returns, strategic diversification, and U.S. market expansion. For investors assessing SCOR SE, these data points-EGPI +1.5%, proposed €1.80 dividend, Berenberg PT €24.00, and a >12% ROE target under Forward 2026-offer measurable milestones to track execution against.

Further detail on corporate guiding principles can be found here: Mission Statement, Vision, & Core Values (2026) of SCOR SE.